Zenas BioPharma, Inc. (ZBIO) Operating income 2023–2025
Zenas BioPharma, Inc. (ZBIO) annual operating income history from SEC filings — each fiscal year as reported.
-$383.1MFY2025 · since FY2023: -$37.1M → -$383.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$383.1M | -133.7% |
| FY2024 | -$163.9M | -341.2% |
| FY2023 | -$37.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ZBIO financial trends
ZBIO RevenueZBIO Net incomeZBIO Net marginZBIO Gross profitZBIO Gross marginZBIO Operating marginZBIO Operating cash flowZBIO Free cash flowZBIO Capital expendituresZBIO Return on equityZBIO Stock buybacksZBIO Dividends paidZBIO Total assetsZBIO Total liabilitiesZBIO Shareholders’ equityZBIO overview →